Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01525485 · ClinicalTrials.gov registry record
Vaginal Electrical Stimulation Versus Neuromodulation
A clinical trial, sponsored by University of Oklahoma.
- Completed
- Registry status
- 34
- Enrollment target
NCT01525485: Completed study, sponsored by University of Oklahoma.
NCT01525485 is a clinical trial that has completed, run by University of Oklahoma. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01525485 has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
This prospective study compares quality of life measures of patients with refractory overactive bladder, between two modes of neuromodulation: vaginal electrical stimulation (Group A) and sacral nerve stimulation (Group B). The specific aims are: 1\. To characterize patient symptom bother score, quality of life, and body image scores in patients obtaining sacral nerve stimulation, as compared to vaginal electrical stimulation. \- Hypothesis 1: Both modes of neuromodulation will impact patients' scores in quality of life, patient symptoms, and body image questionnaires.
Primary Outcome
\>50% improvement in symptoms and decrease in frequency of voids and episodes of nocturia. Subjective outcomes will be measured by improvement in scores on the UDI-6, KHG, and MBIS.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2011-03 |
| Est. Completion | 2016-04 |
What the finished NCT01525485 record still lists
NCT01525485 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01525485 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01525485 about?
NCT01525485 is a clinical study titled "Vaginal Electrical Stimulation Versus Neuromodulation". This prospective study compares quality of life measures of patients with refractory overactive bladder, between two modes of neuromodulation: vaginal electrical stimulation (Group A) and sacral nerve stimulation (Group B). The specific aims are: 1\. To characterize patient symptom bother score, q...
What is the current status of trial NCT01525485?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2011-03. Estimated completion is 2016-04.
Who is sponsoring clinical trial NCT01525485?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia